Why is GuangYuYuan Chinese Herbal Medicine Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 3.39%
- The company has been able to generate a Return on Capital Employed (avg) of 3.39% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of 5.61% and Operating profit at 41.38% over the last 5 years
3
Flat results in Sep 25
- NET SALES(Q) At CNY 281.44 MM has Fallen at -15.47%
- NET PROFIT(Q) Lowest at CNY 2.03 MM
- EPS(Q) Lowest at CNY 0
4
With ROE of 5.78%, it has a very expensive valuation with a 5.66 Price to Book Value
- Over the past year, while the stock has generated a return of -1.20%, its profits have fallen by -37.9%
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -1.20% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is GuangYuYuan Chinese Herbal Medicine Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-5.64%
-0.84
26.20%
China Shanghai Composite
16.01%
1.58
14.20%
Quality key factors
Factor
Value
Sales Growth (5y)
5.61%
EBIT Growth (5y)
41.38%
EBIT to Interest (avg)
-0.81
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
0.72
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.39%
ROE (avg)
3.01%
Valuation Key Factors 
Factor
Value
P/E Ratio
98
Industry P/E
Price to Book Value
5.66
EV to EBIT
100.25
EV to EBITDA
68.00
EV to Capital Employed
6.52
EV to Sales
6.90
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.50%
ROE (Latest)
5.78%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
7What is working for the Company
NET SALES(9M)
At CNY 1,051.32 MM has Grown at 17.66%
DEBTORS TURNOVER RATIO(HY)
Highest at 2.53 times
RAW MATERIAL COST(Y)
Fallen by 1.69% (YoY
NET PROFIT(9M)
Higher at CNY 78.88 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -14.45 %
-11What is not working for the Company
NET SALES(Q)
At CNY 281.44 MM has Fallen at -15.47%
NET PROFIT(Q)
Lowest at CNY 2.03 MM
EPS(Q)
Lowest at CNY 0
Here's what is working for GuangYuYuan Chinese Herbal Medicine Co., Ltd.
Debtors Turnover Ratio
Highest at 2.53 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Debt-Equity Ratio
Lowest at -14.45 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by 1.69% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for GuangYuYuan Chinese Herbal Medicine Co., Ltd.
Net Profit
At CNY 2.03 MM has Fallen at -91.16%
over average net sales of the previous four periods of CNY 22.93 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Net Sales
At CNY 281.44 MM has Fallen at -15.47%
over average net sales of the previous four periods of CNY 332.93 MMMOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Net Profit
Lowest at CNY 2.03 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
EPS
Lowest at CNY 0
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)






